ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research.
Adolescent
Adult
Aged
Anti-HIV Agents
/ adverse effects
Antihypertensive Agents
/ therapeutic use
Chronic Disease
Comorbidity
Diffusion of Innovation
Female
HIV Infections
/ diagnosis
HIV Long-Term Survivors
Health Behavior
Health Status
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/ therapeutic use
Implementation Science
Male
Middle Aged
Noncommunicable Diseases
/ epidemiology
Preventive Health Services
Protective Factors
Respiratory Therapy
Risk Assessment
Risk Factors
Risk Reduction Behavior
Translational Research, Biomedical
Viral Load
Young Adult
Antiretroviral therapy
COPD
Cardiovascular disease
Comorbidities
HIV
Implementation science
Journal
Progress in cardiovascular diseases
ISSN: 1873-1740
Titre abrégé: Prog Cardiovasc Dis
Pays: United States
ID NLM: 0376442
Informations de publication
Date de publication:
Historique:
received:
11
03
2020
accepted:
11
03
2020
pubmed:
23
3
2020
medline:
23
6
2020
entrez:
23
3
2020
Statut:
ppublish
Résumé
Antiretroviral therapy (ART) prevented premature mortality and improved the quality of life among people living with the human immunodeficiency virus (PLWH), such that now more than half of PLWH in the United States are 50 years of age and older. Increased longevity among PLWH has resulted in a significant rise in chronic, comorbid diseases. However, the implementation of guideline-based interventions for preventing, treating, and managing such age-related, chronic conditions among the HIV population is lacking. The PRECluDE consortium supported by the Center for Translation Research and Implementation Science at the National Heart, Lung, and Blood Institute catalyzes implementation research on proven-effective interventions for co-occurring heart, lung, blood, and sleep diseases and conditions among PLWH. These collaborative research studies use novel implementation frameworks with HIV, mental health, cardiovascular, and pulmonary care to advance comprehensive HIV and chronic disease healthcare in a variety of settings and among diverse populations.
Identifiants
pubmed: 32199901
pii: S0033-0620(20)30056-6
doi: 10.1016/j.pcad.2020.03.006
pmc: PMC7237329
mid: NIHMS1583099
pii:
doi:
Substances chimiques
Anti-HIV Agents
0
Antihypertensive Agents
0
Hydroxymethylglutaryl-CoA Reductase Inhibitors
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-91Subventions
Organisme : NHLBI NIH HHS
ID : U01 HL142104
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL123341
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL142107
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL142109
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL142099
Pays : United States
Organisme : HSRD VA
ID : IK6 HX003161
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL142103
Pays : United States
Informations de copyright
Published by Elsevier Inc.
Références
J Gen Intern Med. 2019 Sep;34(9):1782-1789
pubmed: 31240605
Circulation. 2004 Sep 28;110(13):1761-6
pubmed: 15381652
Int J Chron Obstruct Pulmon Dis. 2018 Aug 27;13:2587-2601
pubmed: 30214177
J Am Heart Assoc. 2018 Dec 18;7(24):e010345
pubmed: 30526249
Prog Cardiovasc Dis. 2020 Mar - Apr;63(2):125-133
pubmed: 32035124
Ann Intern Med. 1992 Jan 15;116(2):124-8
pubmed: 1727615
Ann Intern Med. 2000 Mar 7;132(5):369-72
pubmed: 10691587
Implement Sci. 2007 Dec 09;2:42
pubmed: 18067681
Prog Cardiovasc Dis. 2020 Mar - Apr;63(2):101-108
pubmed: 32109483
Clin Infect Dis. 2016 Aug 1;63(3):407-13
pubmed: 27143663
BMC Public Health. 2015 Oct 16;15:1056
pubmed: 26474979
PLoS One. 2018 Oct 1;13(10):e0204826
pubmed: 30273368
Circulation. 2015 Jul 28;132(4):227-9
pubmed: 26124184
JAMA Intern Med. 2014 Feb 1;174(2):186-93
pubmed: 24247275
BMC Infect Dis. 2018 Jun 5;18(1):258
pubmed: 29866059
Circulation. 2019 Jul 9;140(2):e98-e124
pubmed: 31154814
J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e26-e29
pubmed: 28520617
J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S26-31
pubmed: 23673882
AIDS. 2018 Feb 20;32(4):487-493
pubmed: 29135579
MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55
pubmed: 12027060
J Infect Dis. 2017 Dec 19;216(12):1525-1533
pubmed: 29253205
Prev Chronic Dis. 2018 Jan 04;15:E02
pubmed: 29300695
Chest. 2006 Nov;130(5):1326-33
pubmed: 17099007
Arch Intern Med. 2011 Jul 11;171(13):1173-80
pubmed: 21747013
JAMA. 2016 Nov 1;316(17):1759-1760
pubmed: 27802553
AIDS. 2017 Apr 24;31(7):965-971
pubmed: 28121706
J Acquir Immune Defic Syndr. 2015 May 1;69(1):68-74
pubmed: 25942460
AIDS. 2016 Feb 20;30(4):583-90
pubmed: 26558731
Ann Intern Med. 2009 Nov 17;151(10):687-95
pubmed: 19920269
J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):568-576
pubmed: 28520615
Psychosom Med. 2008 Jun;70(5):539-45
pubmed: 18519880
Patient Educ Couns. 2001 Aug;44(2):119-27
pubmed: 11479052
J Int Assoc Provid AIDS Care. 2013 Mar-Apr;12(2):117-21
pubmed: 22965693
Clin Infect Dis. 2012 Nov;55(9):1228-35
pubmed: 22776851
J Assoc Nurses AIDS Care. 2013 Jul-Aug;24(4):355-67
pubmed: 23790278
J Clin Lipidol. 2014 Sep-Oct;8(5):473-88
pubmed: 25234560
Psychosom Med. 2008 Jun;70(5):531-8
pubmed: 18541904
AIDS Patient Care STDS. 2009 Apr;23(4):259-66
pubmed: 19260772
Am J Cardiol. 2016 Jan 15;117(2):214-20
pubmed: 26639041
J Clin Lipidol. 2015 Nov-Dec;9(6 Suppl):S1-122.e1
pubmed: 26699442
Am Heart J. 2019 Oct;216:91-101
pubmed: 31419622
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Circulation. 2016 May 31;133(22):2197-205
pubmed: 27245648
Circulation. 2008 Jul 8;118(2):198-210
pubmed: 18566320
BMC Fam Pract. 2008 Jul 08;9:42
pubmed: 18611255
Am J Respir Crit Care Med. 2011 Feb 1;183(3):388-95
pubmed: 20851926
Circulation. 2019 Sep 10;140(11):e563-e595
pubmed: 30879339
Ann Intern Med. 2018 Apr 17;168(8):541-549
pubmed: 29554692
Am J Public Health. 2019 Jan;109(S1):S72-S78
pubmed: 30699019
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28376193
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
AIDS Care. 2004;16 Suppl 1:S97-120
pubmed: 15736824
Prog Cardiovasc Dis. 2020 Mar - Apr;63(2):109-117
pubmed: 32084445
Circulation. 2010 Feb 2;121(4):586-613
pubmed: 20089546
Lancet HIV. 2019 Feb;6(2):e93-e104
pubmed: 30683625
BMC Health Serv Res. 2014 Oct 20;14:469
pubmed: 25331607
Diabetes Care. 2014 Aug;37(8):2240-5
pubmed: 24804696
AIDS. 2016 Jan 28;30(3):455-63
pubmed: 26765938
Am Heart J. 2007 Jun;153(6):918-24
pubmed: 17540191
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):271-8
pubmed: 23979001
Prog Cardiovasc Dis. 2020 Mar - Apr;63(2):92-100
pubmed: 32092444
PLoS One. 2017 Oct 23;12(10):e0186638
pubmed: 29059202
Prev Med Rep. 2017 Apr 04;6:322-328
pubmed: 28451518
Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45
pubmed: 24222016
Psychosom Med. 2009 Nov;71(9):1012-7
pubmed: 19834051
Am J Cardiol. 2015 Jun 15;115(12):1760-6
pubmed: 25907504
Ann Intern Med. 2016 Jan 19;164(2):114-9
pubmed: 26595370
J Gen Intern Med. 2005 Dec;20(12):1142-5
pubmed: 16423106
JMIR Res Protoc. 2013 Jan 22;2(1):e8
pubmed: 23612564
J Clin Lipidol. 2017 Jan - Feb;11(1):61-69
pubmed: 28391912
J Am Heart Assoc. 2017 Nov 14;6(11):
pubmed: 29138182
Ann Am Thorac Soc. 2019 Jun;16(6):707-714
pubmed: 30822098
Womens Health Issues. 2011 Nov;21(6 Suppl):S255-60
pubmed: 22055676
Front Public Health. 2019 Mar 29;7:64
pubmed: 30984733
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Curr Infect Dis Rep. 2014 Jun;16(6):406
pubmed: 24844467
Clin Infect Dis. 2011 Mar 15;52(6):793-800
pubmed: 21367734
J Am Coll Cardiol. 2017 Mar 28;69(12):1617-1636
pubmed: 27825770
Psychol Assess. 2015 Sep;27(3):965-74
pubmed: 25984638
Clin Infect Dis. 2016 Oct 1;63(7):966-975
pubmed: 27358352
JAMA. 1990 Jan 26;263(4):549-56
pubmed: 2104640
Clin Infect Dis. 2012 Dec;55(11):1550-7
pubmed: 22942209
Vasc Med. 2018 Oct;23(5):476-477
pubmed: 30101683
J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):280-8
pubmed: 26181820
J Adv Nurs. 2010 Dec;66(12):2772-84
pubmed: 20831570